Introduction {#s1}
============

During their growth, development and reproduction plants use cell separation processes to detach no-longer required, damaged or senescent organs. Abscission of floral organs in Arabidopsis is a model system to study these cell separation processes in molecular detail ([@bib1]). The LRR-RKs HAESA (greek: to adhere to) and HAESA-LIKE 2 (HSL2) redundantly control floral abscission ([@bib10]; [@bib23]; [@bib48]). Loss-of-function of the secreted small protein *INFLORESCENCE DEFICIENT IN ABSCISSION (*IDA) causes floral organs to remain attached while its over-expression leads to premature shedding ([@bib7]; [@bib47]). Full-length IDA is proteolytically processed and a conserved stretch of 20 amino-acids (termed EPIP) can rescue the IDA loss-of-function phenotype ([Figure 1A](#fig1){ref-type="fig"}) ([@bib48]). It has been demonstrated that a dodecamer peptide within EPIP is able to activate HAESA and HSL2 in transient assays in tobacco cells ([@bib9]). This sequence motif is highly conserved among IDA family members (IDA-LIKE PROTEINS, IDLs) and contains a central Pro residue, presumed to be post-translationally modified to hydroxyproline (Hyp; [Figure 1A](#fig1){ref-type="fig"}) ([@bib7]; [@bib9]). The available genetic and biochemical evidence suggests that IDA and HAESA together control floral abscission, but it is poorly understood if IDA is directly sensed by the receptor kinase HAESA and how IDA binding at the cell surface would activate the receptor.10.7554/eLife.15075.003Figure 1.The peptide hormone IDA binds to the HAESA LRR ectodomain.(**A**) Multiple sequence alignment of selected IDA family members. The conserved PIP motif is highlighted in yellow, the central Hyp in blue. The PKGV motif present in our N-terminally extended IDA peptide is highlighted in red. (**B**) Isothermal titration calorimetry of the HAESA ectodomain vs. IDA and including the synthetic peptide sequence. (**C**) Structure of the HAESA -- IDA complex with HAESA shown in blue (ribbon diagram). IDA (in bonds representation, surface view included) is depicted in yellow. The peptide binding pocket covers HAESA LRRs 2--14. (**D**) Close-up view of the entire IDA (in yellow) peptide binding site in HAESA (in blue). Details of the interactions between the central Hyp anchor in IDA and the C-terminal Arg-His-Asn motif with HAESA are highlighted in (**E**) and (**F**), respectively. Hydrogren bonds are depicted as dotted lines (in magenta), a water molecule is shown as a red sphere.**DOI:** [http://dx.doi.org/10.7554/eLife.15075.003](10.7554/eLife.15075.003)10.7554/eLife.15075.004Figure 1---figure supplement 1.The HAESA ectodomain folds into a superhelical assembly of 21 leucine-rich repeats.(**A**) SDS PAGE analysis of the purified *Arabidopsis thaliana* HAESA ectodomain (residues 20--620) obtained by secreted expression in insect cells. The calculated molecular mass is 65.7 kDa, the actual molecular mass obtained by mass spectrometry is 74,896 Da, accounting for the N-glycans. (**B**) Ribbon diagrams showing front (left panel) and side views (right panel) of the isolated HAESA LRR domain. The N- (residues 20--88) and C-terminal (residues 593--615) capping domains are shown in yellow, the central 21 LRR motifs are in blue and disulphide bonds are highlighted in green (in bonds representation). (**C**) Structure based sequence alignment of the 21 leucine-rich repeats in HAESA with the plant LRR consensus sequence shown for comparison. Conserved hydrophobic residues are shaded in gray, N-glycosylation sites visible in our structures are highlighted in blue, cysteine residues involved in disulphide bridge formation in green. (**D**) Asn-linked glycans mask the N-terminal portion of the HAESA ectodomain. Oligomannose core structures (containing two N-actylglucosamines and three terminal mannose units) as found in *Trichoplusia ni* cells and in plants were modeled onto the seven glycosylation sites observed in our HAESA structures, to visualize the surface areas potentially not masked by carbohydrate. The HAESA ectodomain is shown in blue (in surface representation), the glycan structures are shown in yellow. Molecular surfaces were calculated with the program MSMS ([@bib42]), with a probe radius of 1.5 Å.**DOI:** [http://dx.doi.org/10.7554/eLife.15075.004](10.7554/eLife.15075.004)10.7554/eLife.15075.005Figure 1---figure supplement 2.Hydrophobic contacts and a hydrogen-bond network mediate the interaction between HAESA and the peptide hormone IDA.(**A**) Details of the IDA binding pocket. HAESA is shown in blue (ribbon diagram), the C-terminal Arg-His-Asn motif (left panel), the central Hyp anchor (center) and the N-terminal Pro-rich motif in IDA (right panel) are shown in yellow (in bonds representation). HAESA interface residues are shown as sticks, selected hydrogen bond interactions are denoted as dotted lines (in magenta). (**B**) View of the complete IDA (in bonds representation, in yellow) binding pocket in HAESA (surface view, in blue). Orientation as in (**A**). (**C**) Structure based sequence alignment of leucine-rich repeats in HAESA with the plant LRR consensus sequence shown for comparison. Residues mediating hydrophobic interactions with the IDA peptide are highlighted in blue, residues contributing to hydrogen bond interactions and/or salt bridges are shown in red. The IDA binding pocket covers LRRs 2--14 and all residues originate from the inner surface of the HAESA superhelix.**DOI:** [http://dx.doi.org/10.7554/eLife.15075.005](10.7554/eLife.15075.005)10.7554/eLife.15075.006Figure 1---figure supplement 3.The IDA-HAESA and SERK1-HAESA complex interfaces are conserved among HAESA and HAESA-like proteins from different plant species.Structure-based sequence alignment of the HAESA family members: *Arabidopsis thaliana* HAESA (Uniprot (<http://www.uniprot.org>) ID P47735), *Arabidopsis thaliana* HSL2 (Uniprot ID C0LGX3), *Capsella rubella* HAESA (Uniprot ID R0F2U6), *Citrus clementina* HSL2 (Uniprot ID V4U227), *Vitis vinifera* HAESA (Uniprot ID F6HM39). The alignment includes a secondary structure assignment calculated with the program DSSP ([@bib24]) and colored according to [Figure 1](#fig1){ref-type="fig"}, with the N- and C-terminal caps and the 21 LRR motifs indicated in orange and blue, respectively. Cysteine residues engaged in disulphide bonds are depicted in green. HAESA residues interacting with the IDA peptide and/or the SERK1 co-receptor kinase ectodomain are highlighted in blue and orange, respectively.**DOI:** [http://dx.doi.org/10.7554/eLife.15075.006](10.7554/eLife.15075.006)

Results {#s2}
=======

IDA directly binds to the LRR domain of HAESA {#s2-1}
---------------------------------------------

We purified the HAESA ectodomain (residues 20--620) from baculovirus-infected insect cells ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}, see Materials and methods) and quantified the interaction of the \~75 kDa glycoprotein with synthetic IDA peptides using isothermal titration calorimetry (ITC). A Hyp-modified dodecamer comprising the highly conserved PIP motif in IDA ([Figure 1A](#fig1){ref-type="fig"}) interacts with HAESA with 1:1 stoichiometry (N) and with a dissociation constant (K*~d~*) of \~20 μM ([Figure 1B](#fig1){ref-type="fig"}). We next determined crystal structures of the apo HAESA ectodomain and of a HAESA-IDA complex, at 1.74 and 1.86 Å resolution, respectively ([Figure 1C](#fig1){ref-type="fig"}; [Figure 1---figure supplement 1B--D](#fig1s1){ref-type="fig"}; [Tables 1](#tbl1){ref-type="table"},[2](#tbl2){ref-type="table"}). IDA binds in a completely extended conformation along the inner surface of the HAESA ectodomain, covering LRRs 2--14 ([Figure 1C,D](#fig1){ref-type="fig"}, [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). The central Hyp64^IDA^ is buried in a specific pocket formed by HAESA LRRs 8--10, with its hydroxyl group establishing hydrogen bonds with the strictly conserved Glu266^HAESA^ and with a water molecule, which in turn is coordinated by the main chain oxygens of Phe289^HAESA^ and Ser311^HAESA^ ([Figure 1E](#fig1){ref-type="fig"}; [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). The restricted size of the Hyp pocket suggests that IDA does not require arabinosylation of Hyp64^IDA^ for activity in vivo, a modification that has been reported for Hyp residues in plant CLE peptide hormones ([@bib39]). The C-terminal Arg-His-Asn motif in IDA maps to a cavity formed by HAESA LRRs 11--14 ([Figure 1D,F](#fig1){ref-type="fig"}). The COO^-^ group of Asn69^IDA^ is in direct contact with Arg407^HAESA^ and Arg409^HAESA^ and HAESA cannot bind a C-terminally extended IDA-SFVN peptide ([Figures 1D,F](#fig1){ref-type="fig"}, [2D](#fig2){ref-type="fig"}). This suggests that the conserved Asn69^IDA^ may constitute the very C-terminus of the mature IDA peptide *in planta* and that active IDA is generated by proteolytic processing from a longer pre-protein ([@bib48]). Mutation of Arg417^HSL2^ (which corresponds to Arg409^HAESA^) causes a loss-of-function phenotype in HSL2, which indicates that the peptide binding pockets in different HAESA receptors have common structural and sequence features ([@bib36]). Indeed, we find many of the residues contributing to the formation of the IDA binding surface in HAESA to be conserved in HSL2 and in other HAESA-type receptors in different plant species ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). A N-terminal Pro-rich motif in IDA makes contacts with LRRs 2--6 of the receptor ([Figure 1D](#fig1){ref-type="fig"}, [Figure 1---figure supplement 2A--C](#fig1s2){ref-type="fig"}). Other hydrophobic and polar interactions are mediated by Ser62^IDA^, Ser65^IDA^ and by backbone atoms along the IDA peptide ([Figure 1D](#fig1){ref-type="fig"}, [Figure 1---figure supplement 2A--C](#fig1s2){ref-type="fig"}).10.7554/eLife.15075.007Figure 2.Active IDA-family peptide hormones are hydroxyprolinated dodecamers.Close-up views of (**A**) IDA, (**B**) the N-terminally extended PKGV-IDA and (**C**) IDL1 bound to the HAESA hormone binding pocket (in bonds representation, in yellow) and including simulated annealing 2F~o~--F~c~ omit electron density maps contoured at 1.0 σ. Note that Pro58^IDA^ and Leu67^IDA^ are the first residues defined by electron density when bound to the HAESA ectodomain. (**D**) Table summaries for equilibrium dissociation constants (K*~d~*), binding enthalpies (ΔH), binding entropies (ΔS) and stoichoimetries (N) for different IDA peptides binding to the HAESA ectodomain ( ± fitting errors; n.d. no detectable binding). (**E**) Structural superposition of the active IDA (in bonds representation, in gray) and IDL1 peptide (in yellow) hormones bound to the HAESA ectodomain. Root mean square deviation (r.m.s.d.) is 1.0 Å comparing 100 corresponding atoms.**DOI:** [http://dx.doi.org/10.7554/eLife.15075.007](10.7554/eLife.15075.007)10.7554/eLife.15075.008Figure 3.The receptor kinase SERK1 acts as a HAESA co-receptor and promotes high-affinity IDA sensing.(**A**) Petal break-strength assays measure the force (expressed in gram equivalents) required to remove the petals from the flower of *serk* mutant plants compared to *haesa/hsl2* mutant and Col-0 wild-type flowers. Petal break-strength is measured from positions 1 to 8 along the primary inflorescence where positions 1 is defined as the flower at anthesis (n=15, bars=SD). This treatment-by-position balanced two-way layout was analyzed separately per position, because of the serious interaction, by means of a Dunnett-type comparison against the Col-0 control, allowing for heterogeneous variances ([@bib19]). Petal break-strength was found significantly increased in almost all positions (indicated with a \*) for *haesa/hsl2* and *serk1-1* mutant plants with respect to the Col-0 control. Calculations were performed in R ([@bib40]) (version 3.2.3). (**B**) Analytical size-exclusion chromatography. The HAESA LRR domain elutes as a monomer (black dotted line), as does the isolated SERK1 ectodomain (blue dotted line). A HAESA -- IDA -- SERK1 complex elutes as an apparent heterodimer (red line), while a mixture of HAESA and SERK1 yields two isolated peaks that correspond to monomeric HAESA and SERK1, respectively (black line). Void (V~0~) volume and total volume (V~t~) are shown, together with elution volumes for molecular mass standards (A, Thyroglobulin, 669,000 Da; B, Ferritin, 440,00 Da, C, Aldolase, 158,000 Da; D, Conalbumin, 75,000 Da; E, Ovalbumin, 44,000 Da; F, Carbonic anhydrase, 29,000 Da). A SDS PAGE of the peak fractions is shown alongside. Purified HAESA and SERK1 are \~75 and \~28 kDa, respectively. (**C**) Isothermal titration calorimetry of wild-type and Hyp64[→]{.ul}Pro IDA versus the HAESA and SERK1 ectodomains. The titration of IDA wild-type versus the isolated HAESA ectodomain from [Figure 1B](#fig1){ref-type="fig"} is shown for comparison (red line; n.d. no detectable binding) (**D**) Analytical size-exclusion chromatography in the presence of the IDA Hyp64[→]{.ul}Pro mutant peptide reveals no complex formation between HAESA and SERK1 ectodomains. A SDS PAGE of the peak fractions is shown alongside. (**E**) In vitro kinase assays of the HAESA and SERK1 kinase domains. Wild-type HAESA and SERK1 kinase domains (KDs) exhibit auto-phosphorylation activities (lanes 1 + 3). Mutant (m) versions, which carry point mutations in their active sites (Asp837^HAESA^→Asn, Asp447^SERK1^→Asn) possess no autophosphorylation activity (lanes 2+4). Transphosphorylation activity from the active kinase to the mutated form can be observed in both directions (lanes 5+6). A coomassie-stained gel loading control is shown below.**DOI:** [http://dx.doi.org/10.7554/eLife.15075.008](10.7554/eLife.15075.008)10.7554/eLife.15075.009Table 1.Crystallographic data collection, phasing and refinement statistics for the isolated *A. thaliana* HAESA ectodomain.**DOI:** [http://dx.doi.org/10.7554/eLife.15075.009](10.7554/eLife.15075.009)HAESA NaI shortsoakHAESA apo**PDB-ID**5IXO**Data collection**Space group*P*3~1~ 21*P*3~1~ 21Cell dimensions*a*, *b, c* (Å)148.55, 148.55, 58.30149.87, 149.87, 58.48*α*, β, γ (°)90, 90, 12090, 90, 120Resolution (Å)48.63--2.39 (2.45--2.39)45.75--1.74 (1.85--1.74)R~meas~^\#^0.096 (0.866)0.038 (1.02)CC(1/2)*^\#^*100/86.6100/75.6*I/σ I^\#^*27.9 (4.9)18.7 (1.8)Completeness (%)*^\#^*99.9 (98.6)99.6 (97.4)Redundancy*^\#^*53.1 (29.9)14.4 (14.0)Wilson B-factor (Å^2^)*^\#^*84.4581.10**Refinement**Resolution (Å)45.75 -- 1.74No. reflections71,213*R*~work/~*R*~free~^\$^0.188/0.218**No. atoms**Protein/glycan4,533/126Water71**Res. B-factors (Å^2^)**^\$^Protein77.54Glycan95.98Water73.20**R.m.s deviations**^\$^Bond lengths (Å)0.0095Bond angles (°)1.51[^1][^2][^3]10.7554/eLife.15075.010Table 2.Crystallographic data collection and refinement statistics for the HAESA -- IDA, -- PKGV-IDA, -- IDL1 and -- IDA -- SERK1 complexes.**DOI:** [http://dx.doi.org/10.7554/eLife.15075.010](10.7554/eLife.15075.010)HAESA -- IDAHAESA -- PKGV-IDAHAESA -- IDL1HAESA -- IDA -- SERK1**PDB-ID**5IXQ5IXT5IYN5IYX**Data collection**Space group*P*3~1~ 21*P*3~1~ 21*P*3~1~ 21*P*2~1~2~1~2~1~Cell dimensions*a*, *b, c* (Å)148.55, 148.55, 58.30148.92, 148.92, 58.02150.18, 150.18, 60.0774.51, 100.46, 142.76*α*, β, γ (°)90, 90, 12090, 90, 12090, 90, 12090, 90, 90Resolution (Å)48.54--1.86\
(1.97--1.86)48.75--1.94 (2,06--1.94)49.16--2.56 (2.72--2.56)47.59--2.43 (2.57--2.43)*R~meas~^\#^*0.057 (1.35)0.037 (0.97)0.056 (1.27)0.113 (1.37)CC(1/2)*^\#^*100/77.9100/80.3100/89.5100/77.6*I*/σ*I^\#^*16.7 (2.0)20.9 (2.4)26.0 (1.9)16.12 (2.0)Completeness*^\#^* (%)99.8 (98.6)99.4 (97.9)99.5 (98.8)99.4 (96.4sRedundancy*^\#^*20.3 (19.1)11.2 (11.1)14.7 (14.7)9.7 (9.3)Wilson B-factor (Å^2^)*^\#^*80.081.789.559.3**Refinement**Resolution (Å)48.54--1.8648.75--1.9449.16--2.5647.59--2.43No. reflections58,55151,55723,83538,969*R*~work/~*R*~free~^\$^0.190/0.2090.183/0.2080.199/0.2360.199/0.235**No. atoms**Protein/Glycan4,541/1764,545/1764,499/1765,965/168Peptide939390112Water39409136**Res. B-factors (Å^2^)**^\$^Protein/Glycan79.48/109.0279.63/113.24102.12/132.4960.05/73.48Peptide87.1989.50125.7451.06Water75.3271.9274.6551.47**R.m.s deviations**^\$^Bond lengths (Å)0.00870.00910.00810.0074Bond angles (°)1.481.471.361.34[^4][^5][^6]

HAESA specifically senses IDA-family dodecamer peptides {#s2-2}
-------------------------------------------------------

We next investigated whether HAESA binds N-terminally extended versions of IDA. We obtained a structure of HAESA in complex with a PKGV-IDA peptide at 1.94 Å resolution ([Table 2](#tbl2){ref-type="table"}). In this structure, no additional electron density accounts for the PKGV motif at the IDA N-terminus ([Figure 2A,B](#fig2){ref-type="fig"}). Consistently, PKGV-IDA and IDA have similar binding affinities in our ITC assays, further indicating that HAESA senses a dodecamer peptide comprising residues 58-69^IDA^ ([Figure 2D](#fig2){ref-type="fig"}).

We next tested if HAESA binds other IDA peptide family members. IDL1, which can rescue IDA loss-of-function mutants when introduced in abscission zone cells, can also be sensed by HAESA, albeit with lower affinity ([Figure 2D](#fig2){ref-type="fig"}) ([@bib48]). A 2.56 Å co-crystal structure with IDL1 reveals that different IDA family members use a common binding mode to interact with HAESA-type receptors ([@bib48]; [@bib8]) ([Figure 2A--C,E](#fig2){ref-type="fig"}, [Table 2](#tbl2){ref-type="table"}). We do not detect interaction between HAESA and a synthetic peptide missing the C-terminal Asn69^IDA^ (ΔN69), highlighting the importance of the polar interactions between the IDA carboxy-terminus and Arg407^HAESA^/Arg409^HAESA^ ([Figures 1F](#fig1){ref-type="fig"}, [2D](#fig2){ref-type="fig"}). Replacing Hyp64^IDA^, which is common to all IDLs, with proline impairs the interaction with the receptor, as does the Lys66^IDA^/Arg67^IDA^ → Ala double-mutant discussed below ([Figure 1A](#fig1){ref-type="fig"}, [2D](#fig2){ref-type="fig"}). Notably, HAESA can discriminate between IDLs and functionally unrelated dodecamer peptides with Hyp modifications, such as CLV3 ([Figures 2D](#fig2){ref-type="fig"}, [7](#fig7){ref-type="fig"}) ([@bib38]).

The co-receptor kinase SERK1 allows for high-affinity IDA sensing {#s2-3}
-----------------------------------------------------------------

Our binding assays reveal that IDA family peptides are sensed by the isolated HAESA ectodomain with relatively weak binding affinities ([Figures 1B](#fig1){ref-type="fig"}, [2A--D](#fig2){ref-type="fig"}). It has been recently reported that SOMATIC EMBRYOGENESIS RECEPTOR KINASES (SERKs) are positive regulators of floral abscission and can interact with HAESA and HSL2 in an IDA-dependent manner ([@bib33]). As all five SERK family members appear to be expressed in the Arabidopsis abscission zone ([@bib37]), we quantified their relative contribution to floral abscission in Arabidopsis using a petal break-strength assay ([@bib27]). Our experiments suggest that among the SERK family members, SERK1 is a positive regulator of floral abscission. We found that the force required to remove the petals of *serk1-1* mutants is significantly higher than that needed for wild-type plants, as previously observed for *haesa/hsl2* mutants ([@bib48]), and that floral abscission is delayed in *serk1-1* ([Figure 3A](#fig3){ref-type="fig"}). The *serk2-2, serk3-1, serk4-1 and serk5-1* mutant lines ([@bib3]) showed a petal break-strength profile not significantly different from wild-type plants. Possibly because SERKs have additional roles in plant development such as in pollen formation ([@bib2]; [@bib13]) and brassinosteroid signaling ([@bib17]), we found that higher-order SERK mutants exhibit pleiotropic phenotypes in the flower ([@bib32]), rendering their analysis and comparison by quantitative petal break-strength assays difficult. We thus focused on analyzing the contribution of SERK1 to HAESA ligand sensing and receptor activation.

In vitro, the LRR ectodomain of SERK1 (residues 24--213) forms stable, IDA-dependent heterodimeric complexes with HAESA in size exclusion chromatography experiments ([Figure 3B](#fig3){ref-type="fig"}). We next quantified the contribution of SERK1 to IDA recognition by HAESA. We found that HAESA senses IDA with a \~60 fold higher binding affinity in the presence of SERK1, suggesting that SERK1 is involved in the specific recognition of the peptide hormone ([Figure 3C](#fig3){ref-type="fig"}). We next titrated SERK1 into a solution containing only the HAESA ectodomain. In this case, there was no detectable interaction between receptor and co-receptor, while in the presence of IDA, SERK1 strongly binds HAESA with a dissociation constant in the mid-nanomolar range ([Figure 3C](#fig3){ref-type="fig"}). This suggests that IDA itself promotes receptor -- co-receptor association, as previously described for the steroid hormone brassinolide ([@bib43]) and for other LRR-RK complexes ([@bib49]; [@bib53]). Importantly, hydroxyprolination of IDA is critical for HAESA-IDA-SERK1 complex formation ([Figure 3C,D](#fig3){ref-type="fig"}). Our calorimetry experiments now reveal that SERKs may render HAESA, and potentially other receptor kinases, competent for high-affinity sensing of their cognate ligands.

Upon IDA binding at the cell surface, the kinase domains of HAESA and SERK1, which have been shown to be active protein kinases ([@bib23]; [@bib44]; [@bib51]), may interact in the cytoplasm to activate each other. Consistently, the HAESA kinase domain can transphosphorylate SERK1 and *vice versa* in in vitro transphosphorylation assays ([Figure 3E](#fig3){ref-type="fig"}). Together, our genetic and biochemical experiments implicate SERK1 as a HAESA co-receptor in the Arabidopsis abscission zone.

SERK1 senses a conserved motif in IDA family peptides {#s2-4}
-----------------------------------------------------

To understand in molecular terms how SERK1 contributes to high-affinity IDA recognition, we solved a 2.43 Å crystal structure of the ternary HAESA -- IDA -- SERK1 complex ([Figure 4A](#fig4){ref-type="fig"}, [Table 2](#tbl2){ref-type="table"}). HAESA LRRs 16--21 and its C-terminal capping domain undergo a conformational change upon SERK1 binding ([Figure 4B](#fig4){ref-type="fig"}). The SERK1 ectodomain interacts with the IDA peptide binding site using a loop region (residues 51-59^SERK1^) from its N-terminal cap ([Figure 4A,C](#fig4){ref-type="fig"}). SERK1 loop residues establish multiple hydrophobic and polar contacts with Lys66^IDA^ and the C-terminal Arg-His-Asn motif in IDA ([Figure 4C](#fig4){ref-type="fig"}). SERK1 LRRs 1--5 and its C-terminal capping domain form an additional zipper-like interface with residues originating from HAESA LRRs 15--21 and from the HAESA C-terminal cap ([Figure 4D](#fig4){ref-type="fig"}). SERK1 binds HAESA using these two distinct interaction surfaces ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}), with the N-cap of the SERK1 LRR domain partially covering the IDA peptide binding cleft.10.7554/eLife.15075.011Figure 4.Crystal structure of a HAESA -- IDA -- SERK1 signaling complex.(**A**) Overview of the ternary complex with HAESA in blue (surface representation), IDA in yellow (bonds representation) and SERK1 in orange (surface view). (**B**) The HAESA ectodomain undergoes a conformational change upon SERK1 co-receptor binding. Shown are C~α~ traces of a structural superposition of the unbound (yellow) and SERK1-bound (blue) HAESA ectodomains (r.m.s.d. is 1.5 Å between 572 corresponding C~α~ atoms). SERK1 (in orange) and IDA (in red) are shown alongside. The conformational change in the C-terminal LRRs and capping domain is indicated by an arrow. (**C**) SERK1 forms an integral part of the receptor\'s peptide binding pocket. The N-terminal capping domain of SERK1 (in orange) directly contacts the C-terminal part of IDA (in yellow, in bonds representation) and the receptor HAESA (in blue). Polar contacts of SERK1 with IDA are shown in magenta, with the HAESA LRR domain in gray. (**D**) Details of the zipper-like SERK1-HAESA interface. Ribbon diagrams of HAESA (in blue) and SERK1 (in orange) are shown with selected interface residues (in bonds representation). Polar interactions are highlighted as dotted lines (in magenta).**DOI:** [http://dx.doi.org/10.7554/eLife.15075.011](10.7554/eLife.15075.011)

The four C-terminal residues in IDA (Lys66^IDA^-Asn69^IDA^) are conserved among IDA family members and are in direct contact with SERK1 ([Figures 1A](#fig1){ref-type="fig"}, [4C](#fig4){ref-type="fig"}). We thus assessed their contribution to HAESA -- SERK1 complex formation. Deletion of the buried Asn69^IDA^ completely inhibits receptor -- co-receptor complex formation and HSL2 activation ([Figure 5A,B](#fig5){ref-type="fig"}) ([@bib9]). A synthetic Lys66^IDA^/Arg67^IDA^ → Ala mutant peptide (IDA K66A/R66A) showed a 10 fold reduced binding affinity when titrated in a HAESA/SERK1 protein solution ([Figures 5A,B](#fig5){ref-type="fig"}, [2D](#fig2){ref-type="fig"}). We over-expressed full-length wild-type IDA or this Lys66^IDA^/Arg67^IDA^ → Ala double-mutant to similar levels in Col-0 Arabidopsis plants ([Figure 5D](#fig5){ref-type="fig"}). We found that over-expression of wild-type IDA leads to early floral abscission and an enlargement of the abscission zone ([Figure 5C--E](#fig5){ref-type="fig"}). In contrast, over-expression of the IDA Lys66^IDA^/Arg67^IDA^ → Ala double mutant significantly delays floral abscission when compared to wild-type control plants, suggesting that the mutant IDA peptide has reduced activity *in planta* ([Figure 5C--E](#fig5){ref-type="fig"}). Comparison of 35S::IDA wild-type and mutant plants further indicates that mutation of Lys66^IDA^/Arg67^IDA^ → Ala may cause a weak dominant negative effect ([Figure 5C--E](#fig5){ref-type="fig"}). In agreement with our structures and biochemical assays, this experiment suggests a role of the conserved IDA C-terminus in the control of floral abscission.10.7554/eLife.15075.012Figure 5.The IDA C-terminal motif is required for HAESA-SERK1 complex formation and for IDA bioactivity.(**A**) Size exclusion chromatography experiments similar to [Figure 3B,D](#fig3){ref-type="fig"} reveal that IDA mutant peptides targeting the C-terminal motif do not form biochemically stable HAESA-IDA-SERK1 complexes. Deletion of the C-terminal Asn69^IDA^ completely inhibits complex formation. Void (V~0~) volume and total volume (V~t~) are shown, together with elution volumes for molecular mass standards (A, Thyroglobulin, 669,000 Da; B, Ferritin, 440,00 Da, C, Aldolase, 158,000 Da; D, Conalbumin, 75,000 Da; E, Ovalbumin, 44,000 Da; F, Carbonic anhydrase, 29,000 Da). Purified HAESA and SERK1 are \~75 and \~28 kDa, respectively. Left panel: IDA K66A/R67A; center: IDA ΔN69, right panel: SDS-PAGE of peak fractions. Note that the HAESA and SERK1 input lanes have already been shown in [Figure 3D](#fig3){ref-type="fig"}. (**B**) Isothermal titration thermographs of wild-type and mutant IDA peptides titrated into a HAESA - SERK1 mixture in the cell. Table summaries for calorimetric binding constants and stoichoimetries for different IDA peptides binding to the HAESA -- SERK1 ectodomain mixture ( ± fitting errors; n.d. no detectable binding) are shown alongside. (**C**) Quantitative petal break-strength assay for Col-0 wild-type flowers and 35S::IDA wild-type and 35S::IDA K66A/R67A mutant flowers. Petal break is measured from positions 1 to 8 along the primary inflorescence where positions 1 is defined as the flower at anthesis (n=15, bars=SD). The three treatment groups in this unbalanced one-way layout were compared by Tukey's all-pairs comparison procedure using the package multcomp ([@bib21]) in R ([@bib40]) (version 3.2.3). 35S::IDA plants showed significantly increased abscission compared to Col-0 controls in inflorescence positions 2 and 3 (a). Up to inflorescence position 4, petal break in 35S::IDA K66A/R67A mutant plants was significantly increased compared to both Col-0 control plants (b) and 35S::IDA plants (c) (**D**) Normalized expression levels (relative expression ± standard error; *ida*: -0.02 ± 0.001; Col-0: 1 ± 0.11; 35S::IDA 124 ± 0.75; 35S::IDA K66A/R67A: 159 ± 0.58) of IDA wild-type and mutant transcripts in the 35S promoter over-expression lines analyzed in (**C**). (**E**) Magnified view of representative abscission zones from 35S::IDA, Col-0 wild-type and 35S::IDA K66A/R67A double-mutant T3 transgenic lines. 15 out of 15 35S::IDA plants, 0 out of 15 Col-0 plants and 0 out of 15 35S::IDA K66A/R67A double-mutant plants, showed an enlarged abscission zone, respectively (3 independent lines were analyzed).**DOI:** [http://dx.doi.org/10.7554/eLife.15075.012](10.7554/eLife.15075.012)

Discussion {#s3}
==========

In contrast to animal LRR receptors, plant LRR-RKs harbor spiral-shaped ectodomains and thus they require shape-complementary co-receptor proteins for receptor activation ([@bib22]). For a rapidly growing number of plant signaling pathways, SERK proteins act as these essential co-receptors ([@bib53]; [@bib32]; [@bib33]; [@bib5]). SERK1 has been previously reported as a positive regulator in plant embryogenesis ([@bib20]; [@bib41]), male sporogenesis ([@bib2]; [@bib13]), brassinosteroid signaling ([@bib3]; [@bib17]; [@bib43]) and in phytosulfokine perception ([@bib53]). Recent findings by [@bib33] and our mechanistic studies now also support a positive role for SERK1 in floral abscission. As *serk1-1* mutant plants show intermediate abscission phenotypes when compared to *haesa/hsl2* mutants, SERK1 likely acts redundantly with other SERKs in the abscission zone ([Figure 3A](#fig3){ref-type="fig"}). It has been previously suggested that SERK1 can inhibit cell separation ([@bib28]). However our results show that SERK1 also can activate this process upon IDA sensing, indicating that SERKs may fulfill several different functions in the course of the abscission process.

While the sequence of the mature IDA peptide has not been experimentally determined *in planta* ([@bib48]), our HAESA-IDA complex structures and calorimetry assays suggest that active IDLs are hydroxyprolinated dodecamers. It will be thus interesting to see if proteolytic processing of full-length IDA in vivo is regulated in a cell-type or tissue-specific manner. The central Hyp residue in IDA is found buried in the HAESA peptide binding surface and thus this post-translational modification may regulate IDA bioactivity. Our comparative structural and biochemical analysis further suggests that IDLs share a common receptor binding mode, but may preferably bind to HAESA, HSL1 or HSL2 in different plant tissues and organs.

In our quantitative biochemical assays, the presence of SERK1 dramatically increases the HAESA binding specificity and affinity for IDA. This observation is consistent with our complex structure in which receptor and co-receptor together form the IDA binding pocket. The fact that SERK1 specifically interacts with the very C-terminus of IDLs may allow for the rational design of peptide hormone antagonists, as previously demonstrated for the brassinosteroid pathway ([@bib35]; [@bib43]). Importantly, our calorimetry assays reveal that the SERK1 ectodomain binds HAESA with nanomolar affinity, but only in the presence of IDA ([Figure 3C](#fig3){ref-type="fig"}). This ligand-induced formation of a receptor -- co-receptor complex may allow the HAESA and SERK1 kinase domains to efficiently trans-phosphorylate and activate each other in the cytoplasm. It is of note that our reported binding affinities for IDA and SERK1 have been measured using synthetic peptides and the isolated HAESA and SERK1 ectodomains, and thus might differ in the context of the full-length, membrane-embedded signaling complex.

Comparison of our HAESA -- IDA -- SERK1 structure with the brassinosteroid receptor signaling complex, where SERK1 also acts as co-receptor ([@bib43]), reveals an overall conserved mode of SERK1 binding, while the ligand binding pockets map to very different areas in the corresponding receptors (LRRs 2 -- 14; HAESA; LRRs 21 -- 25, BRI1) and may involve an island domain (BRI1) or not (HAESA) ([Figure 6A](#fig6){ref-type="fig"}). Several residues in the SERK1 N-terminal capping domain (Thr59^SERK1^, Phe61^SERK1^) and the LRR inner surface (Asp75^SERK1^, Tyr101^SERK1^, SER121^SERK1^, Phe145^SERK1^) contribute to the formation of both complexes ([Figures 4C,D](#fig4){ref-type="fig"}, [6B](#fig6){ref-type="fig"}) ([@bib43]). In addition, residues 53-55^SERK1^ from the SERK1 N-terminal cap mediate specific interactions with the IDA peptide ([Figures 4C](#fig4){ref-type="fig"}, [6B](#fig6){ref-type="fig"}). These residues are not involved in the sensing of the steroid hormone brassinolide ([@bib43]). In both cases however, the co-receptor completes the hormone binding pocket. This fact together with the largely overlapping SERK1 binding surfaces in HAESA and BRI1 allows us to speculate that SERK1 may promote high-affinity peptide hormone and brassinosteroid sensing by simply slowing down dissociation of the ligand from its cognate receptor.10.7554/eLife.15075.013Figure 6.SERK1 uses partially overlapping surface areas to activate different plant signaling receptors.(**A**) Structural comparison of plant steroid and peptide hormone membrane signaling complexes. Left panel: Ribbon diagram of HAESA (in blue), SERK1 (in orange) and IDA (in bonds and surface represention). Right panel: Ribbon diagram of the plant steroid receptor BRI1 (in blue) bound to brassinolide (in gray, in bonds representation) and to SERK1, shown in the same orientation (PDB-ID. 4lsx) ([@bib43]). (**B**) View of the inner surface of the SERK1 LRR domain (PDB-ID 4lsc ([@bib43]), surface representation, in gray). A ribbon diagram of SERK1 in the same orientation is shown alongside. Residues interacting with the HAESA or BRI1 LRR domains are shown in orange or magenta, respectively.**DOI:** [http://dx.doi.org/10.7554/eLife.15075.013](10.7554/eLife.15075.013)

Our experiments reveal that SERK1 recognizes a C-terminal Arg-His-Asn motif in IDA. Importantly, this motif can also be found in other peptide hormone families ([@bib26]; [@bib30]; [@bib50]) ([Figure 7](#fig7){ref-type="fig"}). Among these are the CLE peptides regulating stem cell maintenance in the shoot and the root ([@bib11]). It is interesting to note, that CLEs in their mature form are also hydroxyprolinated dodecamers, which bind to a surface area in the BARELY ANY MERISTEM 1 receptor that would correspond to part of the IDA binding cleft in HAESA ([@bib26]; [@bib38]; [@bib46]). Diverse plant peptide hormones may thus also bind their LRR-RK receptors in an extended conformation along the inner surface of the LRR domain and may also use small, shape-complementary co-receptors for high-affinity ligand binding and receptor activation.10.7554/eLife.15075.014Figure 7.Different plant peptide hormone families contain a C-terminal (Arg)-His-Asn motif, which in IDA represents the co-receptor recognition site.Structure-guided multiple sequence alignment of IDA and IDA-like peptides with other plant peptide hormone families, including CLAVATA3 -- EMBRYO SURROUNDING REGION-RELATED (CLV3/CLE), ROOT GROWTH FACTOR -- GOLVEN (RGF/GLV), PRECURSOR GENE PROPEP1 (PEP1) from *Arabidopsis thaliana*. The conserved (Arg)-His-Asn motif is highlighted in red, the central Hyp residue in IDLs and CLEs is marked in blue.**DOI:** [http://dx.doi.org/10.7554/eLife.15075.014](10.7554/eLife.15075.014)

Materials and methods {#s4}
=====================

Protein expression and purification {#s4-1}
-----------------------------------

Synthetic genes coding for the *Arabidopsis thaliana* HAESA (residues 20--620) and SERK1 ectodomains (residues 24--213, carrying Asn115→Asp and Asn163→Gln mutations), codon optimized for expression in *Trichoplusia ni* (Geneart, Germany), were cloned into a modified pBAC-6 transfer vector (Novagen, Billerica, MA), providing an azurocidin signal peptide and a C-terminal TEV (tobacco etch virus protease) cleavable Strep-9xHis tandem affinity tag. Recombinant baculoviruses were generated by co-transfecting transfer vectors with linearised baculovirus DNA (ProFold-ER1, AB vector, San Diego, CA) followed by viral amplification in *Spodoptera frugiperda* Sf9 cells. The HAESA and SERK1 ectodomains were individually expressed in *Trichoplusia ni* Tnao38 cells ([@bib18]) using a multiplicity of infection of 3, and harvested from the medium 2 days post infection by tangential flow filtration using 30 kDa MWCO and 10 kDa MWCO (molecular weight cut-off) filter membranes (GE Healthcare Life Sciences, Pittsburgh, PA), respectively. Proteins were purified separately by sequential Ni^2+^ (HisTrap HP, GE Healthcare) and Strep (Strep-Tactin Superflow high-capacity, IBA, Germany) affinity chromatography. Next, affinity tags were removed by incubating the purified proteins with recombinant Strep-tagged TEV protease in 1:100 molar ratio. The cleaved tag and the protease were separated from HAESA and SERK1 by a second Strep affinity step. The purified HAESA ectodomain was incubated with a synthetic IDA peptide (YVPIPPSA-Hyp-SKRHN, the N-terminal Tyr residue was added to allow for peptide quantification by UV absorbance) and the SERK1 ectodomain in 1:1:1.5 molar ratio. The HAESA-IDA-SERK1 complex was purified by size exclusion chromatography on a Superdex 200 HR10/30 column (GE Healthcare) equilibrated in 20 mM citric acid pH 5.0, 100 mM NaCl). Peak fractions containing the complex were concentrated to \~10 mg/mL and immediately used for crystallization. About 0.2 mg of purified HAESA and 0.1 mg of purified SERK1 protein were obtained from 1 L of insect cell culture, respectively.

Crystallization and data collection {#s4-2}
-----------------------------------

Hexagonal crystals of the isolated HAESA ectodomain developed at room-temperature in hanging drops composed of 1.0 μL of protein solution (5.5 mg/mL) and 1.0 μL of crystallization buffer (21% PEG 3,350, 0.2 M MgCl~2~ · 6 H~2~O, 0.1 M citric acid pH 4.0), suspended above 1.0 mL of crystallization buffer. For structure solution crystals were derivatized and cryo-protected by serial transfer into crystallization buffer supplemented with 0.5 M NaI and 15% ethylene glycol and cryo-cooled in liquid nitrogen. Redundant single-wavelength anomalous diffraction (SAD) data to 2.39 Å resolution were collected at beam-line PXII at the Swiss Light Source (SLS), Villigen, CH with λ=1.7 Å. A native data set to 1.74 Å resolution was collected on a crystal from the same drop cryo-protected by serial transfer into crystallization buffer supplemented with 15% (v/v) ethylene glycol only (λ=1.0 Å; [Table 1](#tbl1){ref-type="table"}).

HAESA complexes with IDA (PIPPSA-Hyp-SKRHN), PKGV-IDA (YPKGVPIPPSA-Hyp-SKRHN) and IDL1 (LVPPSG-Hyp-SMRHN) peptide hormones were obtained by soaking apo crystals in crystallization buffer containing the respective synthetic peptide at a final concentration of 15 mM. Soaked crystals diffracted to 1.86 Å (HAESA -- IDA), 1.94 Å (HAESA-PKGV-IDA) and 2.56 Å resolution (HAESA -- IDL1), respectively ([Table 2](#tbl2){ref-type="table"}). Orthorhombic crystals of the HAESA-IDA-SERK1 complex developed in 18% PEG 8000, MgCl~2~ · 6 H~2~O, 0.1 M citric acid and diffracted to 2.43 Å resolution ([Table 2](#tbl2){ref-type="table"}). Data processing and scaling was done in XDS ([@bib25]) (version: Nov 2014).

Structure solution and refinement {#s4-3}
---------------------------------

The SAD method was used to determine the structure of the isolated HAESA ectodomain. SHELXD ([@bib45]) located 32 iodine sites (CC All/Weak 37.7/14.9). 20 consistent sites were input into the program SHARP ([@bib6]) for phasing and identification of 8 additional sites at 2.39 Å resolution. Refined heavy atom sites and phases were provided to PHENIX.AUTOBUILD ([@bib52]) for density modification and automated model building. The structure was completed in alternating cycles of model building in COOT ([@bib15]) and restrained TLS refinement in REFMAC5 ([@bib34]) (version 5.8.0107) against an isomorphous high resolution native data set. Crystals contain one HAESA monomer per asymmetric unit with a solvent content of \~55%, the final model comprises residues 20 -- 615. The refined structure has excellent stereochemistry, with 93.8% of all residues in the favored region of the Ramachandran plot, no outliers and a PHENIX.MOLPROBITY ([@bib14]) score of 1.34 ([Table 1](#tbl1){ref-type="table"}).

The HAESA -- IDA -- SERK1 complex structure was determined by molecular replacement with the program PHASER ([@bib31]), using the isolated HAESA and SERK1 (PDB-ID: 4LSC) ([@bib43]) LRR domain structures as search models. The solution comprises one HASEA-IDA-SERK1 complex in the asymmetric unit. The structure was completed in iterative cycles of manual model-building in COOT and restrained TLS refinement in REFMAC5. Amino acids whose side-chain position could not be modeled with confidence were truncated to alanine (0.6 -- 1% of total residues), the stereochemistry of N-linked glycan structures was assessed with the CCP4 program PRIVATEER-VALIDATE. The refined model has 94.44% of all residues in the favored region of the Ramachandran plot, no outliers and a PHENIX.MOLPROBITY score of 1.17 ([Table 2](#tbl2){ref-type="table"}). Structural visualization was done with POVScript+ ([@bib16]) and POV-Ray (<http://www.povray.org>).

Size-exclusion chromatography {#s4-4}
-----------------------------

Gel filtration experiments were performed using a Superdex 200 HR 10/30 column (GE Healthcare) pre-equilibrated in 20 mM citric acid (pH 5) and 100 mM NaCl. 100 μL of the isolated HAESA ectodomain (5.5 mg/mL), of the purified SERK1 LRR domain (3 mg/mL) or of mixtures of HAESA and SERK1 (either in the presence or absence of synthetic wild-type IDA, wild-type IDL1 or mutant IDA peptides at a concentration of 25 μM; 10 mg/mL; samples contained HAESA and SERK1 in 1:1 molar ratio) were loaded sequentially onto the column and elution at 0.5 mL/min was monitored by ultraviolet absorbance at 280 nm.

Isothermal titration calorimetry {#s4-5}
--------------------------------

ITC experiments were performed using a Nano ITC (TA Instruments, New Castle, DE) with a 1.0 mL standard cell and a 250 μL titration syringe. Proteins were dialyzed extensively against ITC buffer (20 mM citric acid pH 5.0, 100 mM NaCl) and synthetic wild-type or point-mutant peptides (with wild-type IDA sequence YVPIPPSA-Hyp-SKRHN, PKGV-IDA YPKGVPIPPSA-Hyp-SKRHN, IDA-SFVN YPIPPSA-Hyp-SKRHNSFVN, IDL1 YLVPPSG-Hyp-SMRHN and CLV3 sequence YRTV-Hyp-SG-Hyp-DPLHH) were dissolved in ITC buffer prior to all titrations. Molar protein concentrations for SERK1 and HAESA were calculated using their molar extinction coefficient and a molecular weight of 27,551 and 74,896 Da, respectively (determined by MALDI-TOF mass spectrometry). Experiments were performed at 25°C. A typical experiment consisted of injecting 10 μL aliquots of peptide solution (250 μM) into 20 μM HAESA. The concentrations for the complex titrations were 150 μM of ligand (either wild-type or point-mutant IDA peptides) in the syringe and 10 μM of a 1:1 HAESA -- SERK1 protein mixture in the cell at time intervals of 150 s to ensure that the titration peak returned to the baseline. Binding of SERK1 to HAESA was assessed by titrating SERK1 (100 μM) into a solution containing HAESA (10 μM) in the pre- or absence of 150 μM wild-type IDA peptide. ITC data were corrected for the heat of dilution by subtracting the mixing enthalpies for titrant solution injections into protein free ITC buffer. Data were analyzed using the NanoAnalyze program (version 2.3.6) as provided by the manufacturer.

In vitro kinase trans-phosphorylation assay {#s4-6}
-------------------------------------------

Coding sequences of SERK1 kinase domain (SERK1-KD) (residues 264--625) and HAESA-KD (residues 671--969) were cloned into a modified pET (Novagen) vector providing an TEV-cleavable N-terminal 8xHis-StrepII-Thioredoxin tag. Point mutations were introduced into the SERK1 (Asp447→Asn; mSERK1) and HAESA (Asp837→Asn; mHAESA) coding sequences by site directed mutagenesis, thereby rendering the kinases inactive ([@bib4]). The plasmids were transformed into *E.coli* Rosetta 2 (DE3) (Novagen). Protein expression was induced by adding IPTG to final concentration of 0.5 mM to cell cultures grown to an OD~600~ = 0.6. Cells were then incubated at 16°C for 18 hr, pelleted by centrifugation at 5000 x g and 4°C for 15 min, and resuspended in buffer A (20 mM Tris-HCl pH 8, 500 mM NaCl, 4 mM MgCl~2~ and 2 mM β-Mercaptoethanol) supplemented with 15 mM Imidazole and 0.1% (v/v) Igepal. After cell lysis by sonication, cell debris was removed by centrifugation at 35,000 x g and 4°C for 30 min. The recombinant proteins were isolated by Co^2+^ metal affinity purification using a combination of batch and gravity flow approaches (HIS-Select Cobalt Affinity Gel, Sigma, St. Louis, MO). After washing the resin with the wash buffer (buffer A + 15 mM Imidazole) proteins were eluted in buffer A supplemented with 250 mM Imidazole. All elutions were then dialyzed against 20 mM Tris-HCl pH 8, 250 mM NaCl, 4 mM MgCl~2~ and 0.5 mM TCEP. For SERK1-KD and mSERK1-KD the 8xHis-StrepII-Thioredoxin tag was removed with 6xHis tagged TEV protease. TEV and the cleaved tag were removed by a second metal affinity purification step. Subsequently, all proteins were purified by gel filtration on a Superdex 200 10/300 GL column equilibrated in 20 mM Tris pH 8, 250 mM NaCl, 4 mM MgCl~2~ and 0.5 mM TCEP. Peak fractions were collected and concentrated using Amicon Ultra centrifugation devices (10,000 MWCO). For in vitro kinase assays, 1 μg of HAESA-KD, 0.25 μg of SERK1-KD and 2 μg of mSERK1 and mHAESA were used in a final reaction volume of 20 μl. The reaction buffer consisted of 20 mM Tris pH 8, 250 mM NaCl, 4 mM MgCl~2~ and 0.5 mM TCEP. The reactions were started by the addition of 4 μCi \[γ-^32^P\]-ATP (Perkin-Elmer, Waltham, MA), incubated at room temperature for 45 min and stopped by the addition of 6x SDS-loading dye immediately followed by incubating the samples at 95°C. Proteins of the whole reaction were subsequently separated via SDS-PAGE in 4--15% gradient gels (TGX, Biorad, Hercules, CA) and stained with Instant Blue (Expedeon, San Diego, CA). After pictures were taken of the stained gel, ^32^P-derived signals were visualized by exposing the gel to an X-ray film (Fuji, SuperRX, Valhalla, NY).

Plant material and generation of transgenic lines {#s4-7}
-------------------------------------------------

35S::IDA wild-type and 35S::IDA (R66 → Ala/K67 → Ala) over-expressing transgenic lines in Col-0 background were generated as follows: The constructs were introduced in the destination vector pB7m34GW2 and transferred to *A. tumefaciens* strain pGV2260. Plants were transformed using the floral dip method ([@bib12]). Transformants were selected in medium supplemented with BASTA up to the T3 generation. For phenotyping, plants were grown at 21°C with 50% humidity and a 16h light: 8 hr dark cycle.

RNA analyses {#s4-8}
------------

Plants were grown on ½ Murashige and Skoog (MS) plates supplemented with 1% sucrose. After 7 d, ∼30 to 40 seedlings were collected and frozen in liquid nitrogen. Total RNA was extracted using a RNeasy plant mini kit (Qiagen, Valencia, CA), and 1 μg of the RNA solution obtained was reverse-transcribed using the SuperScritpVILO cDNA synthesis kit (Invitrogen, Grand Island, NY). RT-qPCR amplifications and measurements were performed using a 7900HT Fast Real Time PCR-System by Applied Biosystems (Carlsbad, CA). RT-qPCR amplifications were monitored using SYBR-Green fluorescent stain (Applied Biosystems). Relative quantification of gene expression data was performed using the 2−ΔΔCT (or comparative CT) method ([@bib29]). Expression levels were normalized using the CT values obtained for the *actin2* gene (forward: TGCCAATCTACGAGGGTTTC; reverse: TTCTCGATGGAAGAGCTGGT). For detection and amplification of IDA sequence we used specific primers (forward: TCGTACGATGATGGTTCTGC; reverse: GAATGGGAACGCCTTTAGGT). The presence of a single PCR product was further verified by dissociation analysis in all amplifications. All quantifications were made in quadruplicates on RNA samples obtained from three independent experiments.

Petal break measurements {#s4-9}
------------------------

*serk1-1, serk2-2, serk3-1, serk4-1 and serk5-1* and Col-0 wild-type plants were grown in growth chambers at 22°C under long days (16 hr day/8 hr dark) at a light intensity of 100 µE·m^-2^·sec^-1^. Petal break-strength was quantified as the force in gram equivalents required for removal of a petal from a flower ([@bib7]) when the plants had a minimum of twenty flowers and siliques. Measurements were performed using a load transducer as described in [@bib48]. Break-strength was measured for 15 plants and a minimum of 15 measurements at each position.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Mechanistic insight into a peptide hormone signaling complex mediating floral organ abscission\" to *eLife* for consideration by *eLife*. Your article has been favorably evaluated by John Kuyiyan (Senior editor) and three reviewers, one of whom, (Mingjie Zhang) is a member of our Board of Reviewing Editors.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission. As you will see that the required revisions are essentially clarifications and some additional analysis of existing data in nature.

Summary:

In this work, Hothorn and colleagues investigated the structural basis governing the recognition of peptide hormone IDA during plant floral abscission process. Through an array of complex structures, supplemented with biochemical and genetic experiments, the authors uncovered the IDA recognition mechanism by a co-receptor (HAESA and SERK1) detection mechanism. The structures also reveal the specific recognition mechanism of the 12-residue IDA core peptide sequence by the co-receptors, and suggest that this 12-residue IDA sequence is likely to be the mature peptide hormone functioning in plants. The comparison of the structures of the HAESA/SERK1/IDA complex and the previously determined BRA1/SERK1/brassinolide complex by the same group also suggests a co-receptor pairing mechanism for various plant hormones. The story gives detailed and novel mechanistic insights in the perception of IDA during floral abscission, and is convincing and worthy to be considered for publication in *eLife* with the following revisions.

Key issues which need to be addressed:

1\) As the results reported here rest largely on the interpretation of the structural data, the following points need to be addressed by the authors. i) Temperature factors (Wilson B and residual) are unusually high for the reported resolution. Are there portions of the structure that exhibit more disorder or are these high temperature factors throughout the structure? Are there potential problems with radiation damage due to the high multiplicity? ii) A simulated annealing omit map figure should be provided as the peptides all exhibit very high temperature factors. iii) How many side chains were trimmed due to poor electron density? If this is a significant percentage, it should be noted.

2\) A further discussion comparing the mechanisms of BRI1-BL-SERK1 and HAESA-IDA-SERK1 would be helpful as a structural comparison is presented. As BR1 binds its ligand with high affinity, the low affinity of HAESA for IDA could be further discussed.

3\) Are the results here applicable to the related receptor HSL2? Are the residues that interact with SERK1 and IDA conserved in HSL2?

4\) The authors show that N-terminal extension of the peptide does not impact on binding efficiency, but what would happen if the peptide was extended at the C-terminal end, at the suggested cleavage site? Would cleavage be required for recognition? A brief discussion on this point may help.

5\) [Figure 3C](#fig3){ref-type="fig"}: Could the authors comment on the difference between the blue (SERK1 vs. HAESA-IDA) and the black (IDA vs. HAESA-SERK1) line? SERK1 vs. HAESA-IDA gives a Kd of 75 nM, yet IDA vs. SERK1-HAESA gives a Kd of 350 nM. In the text the authors keep referring to the 75 nM Kd, but not the 350 nM Kd. Is it really fair to say the Kd is 75 nM?

6\) In the Discussion, can the authors comment further on the discrepancy between their study and the study of Lewis et al. (Plant J, 2010) concerning the role of SERK1 in floral abscission? Similarly, could the authors comment on the fact that the LRR-RLP EVD/SOBIR seems to be a negative regulator of the HAESA/HSL2 pathway (Leslie et al., Development, 2010), which seems puzzling given that EVD/SOBIR function is normally restricted to LRR-RLPs (Gust & Felix, Curr Op Plant Biol, 2014).

7\) Given that the central hydroxyproline in IDA is of such crucial importance for binding, isn\'t it surprising that IDAΔ69N does not bind to HAESA at all? Wouldn\'t it be expected that the remaining part of the peptide still binds to HAESA?

8\) [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}: How is it possible that charged amino acids are involved in hydrophobic interactions?

9\) Are the distances shown in the graphical representation of the structures proportional? It would seem that some of the aromatic rings could cause steric hindrance.

10\) Why did the authors decide to express HAESA and SERK1 without signal peptide? Would it make a difference for binding of IDA, if they leave the SP on?

11\) [Figure 7](#fig7){ref-type="fig"}: Are the homologous regions also the active parts of these peptides? And could the authors display amino acids numbers on either side of the fragments?

12\) Have the authors ever measured dissociation of the peptide from the complex? And in this regard, to what does \"highly stable receptor -- co-receptor complex\" refer/compare to?

13\) [Figures 3A](#fig3){ref-type="fig"} and [5C](#fig5){ref-type="fig"} require statistical analyses.

10.7554/eLife.15075.018

Author response

*1) As the results reported here rest largely on the interpretation of the structural data, the following points need to be addressed by the authors. i) Temperature factors (Wilson B and residual) are unusually high for the reported resolution.*

We thank the reviewer(s) for pointing out this issue: Indeed our mean B-values deviate substantially from the expected mean B-values (resolution 1.75 -- 2.00 A, B(Wilson) \~ 27.0 over 5,510 structures in the PDB; Pavel Afonine, personal communication). We would like to note that due to the many N-glycosylation sites dispersed over the HAESA LRR domain (shown in [Figure 1---figure supplement 1D](#fig1s1){ref-type="fig"}), we find relatively few crystal contacts in our P3121 crystal form, which may rationalize our high B-values. We have reanalyzed our space group assignment (using the CCP4 program ZANUDA) and checked for any signs of problems during data collection (ice rings, multiple crystal lattices, splitting, using the programs XDS and XDSSTAT), as well as for twinning and pseudosymmetry (using phenix.xtriage). No such problems appear to exist, our structures refine very well and our refined B-values are in good agreement with our Wilson B-factors (see [Table 2](#tbl2){ref-type="table"}). Thus, the high B-values appear to represent an intrinsic property of our crystals and are not the result of a poor data collection strategy or inappropriate crystallographic analysis.

*Are there portions of the structure that exhibit more disorder or are these high temperature factors throughout the structure?*

Yes. As shown in revised [Figure 4B](#fig4){ref-type="fig"}, the Cterminal LRRs of HAESA in contact with SERK1 in our complex structure appear to be somewhat flexible. [Author response image 1](#fig8){ref-type="fig"}. illustrates that the B-values are significantly higher in the C-terminal part of the HAESA LRR domain (with the Cterminal capping domain being the most flexible), while both the N-terminal LRRs of HAESA (with exception of the LRR N-terminal capping domain) and the IDA peptide appear better ordered in our P3~1~21 crystals form.10.7554/eLife.15075.015Author response image 1.Cα trace of the HAESA LRR domain and IDA peptide colored according to B-factor from low (60.9, in blue) to high (134.7, in red).Mean B-value is 79.5.**DOI:** [http://dx.doi.org/10.7554/eLife.15075.015](10.7554/eLife.15075.015)

*Are there potential problems with radiation damage due to the high multiplicity?*

No. Data were collected at SLS beamline PXIII equipped with a Dectris Pilatus 2M-F detector. We perform all our data collections at very low dose and high multiplicity of measurement, which at this beam-line produces similar results compared to exposing the crystal at higher dose for a smaller angular range. We collected 360 deg with 0.1 deg slices and obtained a Wilson B-value of 80, with no sign of radiation damage in our data processing (subroutine COLSPOT in XDS over all frames). To test the reviewer\'s hypothesis we cut the data after 90 deg (when completeness approaches 100%) and we obtained a Wilson B-value of 78 and a refined mean B-value of around 75. These value do not significantly differ from our presented 360 deg data set and thus it is unlikely that radiation damage produces these high B-values. Again, they rather appear to be an intrinsic property of our crystals.

ii\) A simulated annealing omit map figure should be provided as the peptides all exhibit very high temperature factors.

Thank you for this suggestion. In our first submission, we presented 2Fo-Fc omit electron density maps for our HAESA-IDA/IDL complex structures. As suggested, we now present simulated annealing omit maps in revised [Figure 2A, B](#fig2){ref-type="fig"}, C. The maps were generated like this: phenix.composite_omit_map \*.pdb \*.mtz \*.cif nproc=8 anneal=True We would like to note that our peptide are well ordered in our structures, and their B-values match the B-values of their interacting LRR surface (compare [Author response image 1](#fig8){ref-type="fig"}).

*iii) How many side chains were trimmed due to poor electron density? If this is a significant percentage, it should be noted.*

Here are the requested numbers (trimmed residues out of total residues in asymmetric unit, percentage):

HAESA apo: 7 out of 595 (1%)

HAESA IDA: 6 out of 597 + 12 (1%)

HAESA IDL1: 6 out of 597 + 12 (1%)

HAESA -- IDA -- SERK1: 5 out of 594 + 12 + 185 (0.6%)

We have included a statement in the Methods section that reads: "Amino acids whose side-chain position could not be modeled with confidence were truncated to alanine (0.6 -- 1% of total residues)\[...\]"

*2) A further discussion comparing the mechanisms of BRI1-BL-SERK1 and HAESA-IDA-SERK1 would be helpful as a structural comparison is presented.*

We have expanded our discussion of the HAESA -- SERK1 and BRI1 -- SERK1 interfaces. We now specify the SERK1 residues in contact with both receptors and the SERK1 residues unique to HAESA/IDA sensing. We also comment on the very different ligand binding modes in HAESA and BRI1 and specify that different LRR segments contribute to the formation of the respective steroid and peptide hormone binding pockets. We feel however that an in-depth comparison of the interacting surfaces is beyond the scope of this report and partially redundant with our earlier work (Santiago et al., Science, 2013). In our opinion, such an analysis seems more appropriate for a review on the subject, which we are currently preparing. Our revised Discussion now reads: "Comparison of our HAESA -- IDA -- SERK1 structure with the brassinosteroid receptor signaling complex, where SERK1 also acts as co-receptor (Santiago, Henzler, and Hothorn 2013), reveals an overall conserved mode of SERK1 binding, while the ligand binding pockets map to very different areas in the corresponding receptors (LRRs 2 -- 14; HAESA; LRRs 21 -- 25, BRI1) and may involve an island domain (BRI1) or not (HAESA) ([Figure 6A](#fig6){ref-type="fig"}).\[...\] These residues are not involved in the sensing of the steroid hormone brassinolide (Santiago, Henzler, and Hothorn 2013). In both cases however, the co-receptor completes the hormone binding pocket."

*As BR1 binds its ligand with high affinity, the low affinity of HAESA for IDA could be further discussed.*

High affinity brassinosteroid binding to BRI1 was previously shown using BRI1-enriched plant extracts and radiolabeled brassinolide (Wang et al., Nature410:380-383, 2001). We now know that co-immunoprecipitations of BRI1 from Arabidopsis contain SERK proteins (compare for example Jaillais et al., PNAS, 2011) and thus the reported binding constants likely correspond to steroid binding to BRI1-SERK complexes, not to BRI1 alone. We would thus prefer not to compare the binding affinities for brassinosteroid and peptide hormone ligands at this point.

*3) Are the results here applicable to the related receptor HSL2? Are the residues that interact with SERK1 and IDA conserved in HSL2?*

Yes. We present a structure-based sequence alignment of AtHAESA and AtHSL2, as well as other HAESA-type receptors from different plant species in [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}. In the peptide binding surface, 17 out of 26 contributing amino-acids are conserved among AtHAESA and AtHSL2. 13 out of 19 interacting residues in the HAESA -- SERK1 complex are also present in AtHSL2. We feel that this is strong conservation given that the AtHAESA and AtHSL2 ectodomains share 45% overall sequence identity. We have included a statement in our manuscript that reads: "Indeed, we find many of the residues contributing to the formation of the IDA binding surface in HAESA to be conserved in HSL2 and other HAESA-type receptors in different plant species ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"})."

*4) The authors show that N-terminal extension of the peptide does not impact on binding efficiency, but what would happen if the peptide was extended at the C-terminal end, at the suggested cleavage site?*

Thank you for suggesting this experiment. We synthesized a C-terminally extended version of the IDA peptide (IDA-SFVN with sequence YPIPPSA-Hyp- SKRHN SFVN) and performed quantitative binding assays by ITC. As shown in [Author response image 2](#fig9){ref-type="fig"}, we cannot observe any detectable binding of this C-terminally extended peptide to the HAESA ectodomain, consistent with our crystallographic models that suggest that HAESA specifically senses an active IDA 12mer. We have incorporated this new result in [Figure 2D](#fig2){ref-type="fig"}. We have included a new statement in the manuscript that reads: "The COO^-^ group of Asn69^IDA^ is in direct contact with Arg407^HAESA^ and Arg409^HAESA^ and HAESA cannot bind a C-terminally extended IDA-SFVN peptide ([Figures 1D, F](#fig1){ref-type="fig"}, [2D](#fig2){ref-type="fig"})."10.7554/eLife.15075.016Author response image 2.Isothermal titration calorimetry thermograph of the C-terminally extended IDA-SFVN peptide (200 μM) titrated into a solution containing 20 μM of the purified HAESA ectodomain.No detectable binding is observed.**DOI:** [http://dx.doi.org/10.7554/eLife.15075.016](10.7554/eLife.15075.016)

*Would cleavage be required for recognition? A brief discussion on this point may help.*

Yes. We have modified our manuscript accordingly: "This suggests that the conserved Asn69 may constitute the very C-terminus of the mature IDA peptide *in planta* and that active IDA is generated by proteolytic processing from a longer pre-protein (Stenvik et al. 2008)."

5\) [Figure 3C](#fig3){ref-type="fig"}: Could the authors comment on the difference between the blue (SERK1 vs. HAESA-IDA) and the black (IDA vs. HAESA-SERK1) line? SERK1 vs. HAESA-IDA gives a Kd of 75 nM, yet IDA vs. SERK1-HAESA gives a Kd of 350 nM. In the text the authors keep referring to the 75 nM Kd, but not the 350 nM Kd. Is it really fair to say the Kd is 75 nM?

Yes and No. These are two different experiments. We first measured (by ITC) the binding affinity of IDA (in the syringe) binding to a protein solution containing equimolar ratios of HAESA and SERK1 (K*~d~*is 350 nM in this case). Next, we titrated a concentrated SERK1 solution (in the syringe) into a solution of HAESA containing IDA in 10fold molar excess (K*~d~*in this case is 75 nM). Given that the experimental conditions (protein and peptide concentrations and molar ratios between the components) are very different, we feel that the K*~d~ \'*s obtained by these experiments are in good agreement (4.5 fold difference vs. a 60-260 fold difference when compared to the isolated HAESA ectodomain). Nevertheless, we addressed the reviewer\'s concern by modifying our manuscript which now states: "In this case, there was no detectable interaction between receptor and co-receptor, while in the presence of IDA, SERK1 strongly binds HAESA with a dissociation constant in the mid-nanomolar range. ([Figure 3C](#fig3){ref-type="fig"})."

*6) In the Discussion, can the authors comment further on the discrepancy between their study and the study of Lewis et al. (Plant J, 2010) concerning the role of SERK1 in floral abscission?*

The process of floral organ abscission in Arabidopsis is divided into distinct steps where a gradual loosening of the cell wall between abscising cells can be measured as a reduction in petal breakstrength (Bleecker and Patterson, 1997). During floral abscission in wild-type plants a significant drop in breakstrength occurs shortly before the petals drop (shown in [Figure 3A](#fig3){ref-type="fig"} in our manuscript). Previously reported negative regulators of abscission, such as the transcription factor *KNAT1*, have an earlier reduction in breakstrength, indicative of early cell wall remodeling (Shi et al. 2011). Our results show that *serk1* mutant plants, contrary to *knat1* mutants and wild type, have a delay in cell wall loosening and organ separation ([Figure 3A](#fig3){ref-type="fig"}) thus positively regulating organ separation during abscission. The weaker phenotype when compared to *haesa/hsl2* mutants is likely due to the redundant nature of other SERKs inthe abscission zone (recent work of Meng et al. 2016, cited in the Results and Discussion sections of our manuscript).

It has previously been reported that mutations in *SERK1* can rescue the block in abscission in plants without the functional ADP-ribosylation factor GTPase-activating protein NEVERSHED (NEV) (Lewis et al. 2010). However, as a mutation in *SERK1* is not capable of rescuing the *ida* mutant phenotype (Lewis et al. 2010) and revertant mutants capable of rescuing the abscission defect of *ida* do not complement *nev*, it has been suggested that NEV and IDA function in parallel pathways to promote cell separation (Liu 2013). Our work does not rule out a function for SERK1 in such a parallel pathway, we merely report SERK1 can ALSO act as a positive regulator of abscission by interacting with HAESA in an IDA-dependent manner. We do not observe negative regulation of floral abscission using our SERK1 mutant alleles. Based on the available evidence there is thus little to discuss and speculate about the different functions of SERK1 in abscission, as no molecular mechanism for the negative role of SERK1 in this pathway has been reported thus far. We feel that it is beyond the scope of our manuscript to clarify the different roles of SERK1 in the Arabidopsis abscission zone.

Similarly, could the authors comment on the fact that the LRR-RLP EVD/SOBIR seems to be a negative regulator of the HAESA/HSL2 pathway (Leslie et al., Development, 2010), which seems puzzling given that EVD/SOBIR function is normally restricted to LRR-RLPs (Gust & Felix, Curr Op Plant Biol, 2014).

We did attempt to express and purify the EVR/SOBIR extracellular domain, but in our hands the protein is not properly secreted and hence unfolded. We thus could not further investigate the potential mechanism of EVR/SOBIR in the HAESA pathway.

*7) Given that the central hydroxyproline in IDA is of such crucial importance for binding, isn\'t it surprising that IDAΔ69N does not bind to HAESA at all? Wouldn\'t it be expected that the remaining part of the peptide still binds to HAESA?*

We thank the reviewers for pointing this out to us. Indeed, we find several structural and sequence features in IDA peptide to be important determinants for HAESA binding, namely the correct size of the peptide, the presence of a central Hyp residue and an intact C-terminal Arg-His-Asn motif that is buried in the structure. In the revised manuscript we now provide new experiments (binding of a C-terminal extended IDA peptide to HAESA) that clarifies this point (summarized in revised [Figure 2D](#fig2){ref-type="fig"}). We have revised our statement in the Discussion accordingly: "The central Hyp residue in IDA is found buried in the HAESA peptide binding surfaceand thus this post-translational modification may regulateIDA bioactivity."

*8) [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}: How is it possible that charged amino acids are involved in hydrophobic interactions?*

We apologize for this confusing statement. It now reads: "A N-terminal Pro-rich motif in IDA makes contacts LRRs 2-6 of the receptor([Figure 1D](#fig1){ref-type="fig"}, [Figure 1---figure supplement 2A-C](#fig1s2){ref-type="fig"})."

*9) Are the distances shown in the graphical representation of the structures proportional? It would seem that some of the aromatic rings could cause steric hindrance.*

No. The graphical representation are proportional and e.g. Trp218 in the back of the binding pocket is not producing steric clashes with the peptide with the closest distance being 4.5 A.

*10) Why did the authors decide to express HAESA and SERK1 without signal peptide? Would it make a difference for binding of IDA, if they leave the SP on?*

No. We did express both the HAESA and SERK1 ectodomains fused to the signal peptide of human azurocidin, which provides very efficient secretion of LRR proteins in insect cells (Olczak & Olczak, Anal. Biochem., 2006) (see Methods, subsection "Protein Expression and Purification"). Both the native signal peptides for SERK1 and HAESA as well as the azurocidin signal peptide are being recognized and cleaved by the *Trichoplusia ni* signal peptidase. This results, just like *in planta*, in a mature receptor/coreceptor ectodomain starting with the first α-helix of the N-terminal capping domain (residues 20 and 24, respectively). Thus, there is no reason to believe that the signal peptide would play a role in IDA sensing. Using our system, we cannot produce HAESA and/or SERK1 ectodomains with an intact signal peptide, as this would impair folding and proper secretion of the recombinant proteins.

*11) [Figure 7](#fig7){ref-type="fig"}: Are the homologous regions also the active parts of these peptides?*

Yes. We have included three additional references in the Discussion section of our manuscript, which report the bioactive regions of CLV3/CLE, RGF and PEP peptides shown in [Figure 7](#fig7){ref-type="fig"}. The revised section now reads: "Importantly, this motif can also be found in other peptide hormone families (Kondo et al. 2006; Matsuzaki et al. 2010; Tang et al. 2015)([Figure 7](#fig7){ref-type="fig"}). Among these are the CLE peptides regulating stem cell maintenance in the shoot and the root (Clark, Running, and Meyerowitz 1995). It is interesting to note, that CLEs in their mature form are also hydroxyprolinated dodecamers, which bind to a surface area in the BARELY ANY MERISTEM 1 receptor that would correspond to part of the IDA binding cleft in HAESA (Kondo et al. 2006;Ogawa et al. 2008; Shinohara et al. 2012)."

*And could the authors display amino acids numbers on either side of the fragments?*

Yes. We have now included the residues number of each peptide in [Figure 7](#fig7){ref-type="fig"}.

*12) Have the authors ever measured dissociation of the peptide from the complex?*

No. We have not performed any biochemical experiment that would allow us to quantify the dissociation of the peptide from the ternary complex. In qualitative terms it is however of note that HAESA-IDA-SERK1 complexes do not dissociate in size exclusion chromatography experiments, even when the peptide is not provided in excess or supplied in the running buffer.

*And in this regard, to what does \"highly stable receptor -- co-receptor complex\" refer/compare to?*

The reviewers are correct, we should not claim that the complex is \'highly stable\' if we have not quantified the dissociation rate. The revised sentence reads: "This ligand-induced formation of a receptor -- co-receptor complex may allow the HAESA and SERK1 kinase domains to efficiently trans-phosphorylate and activate each other in the cytoplasm."

13\) [Figures 3A](#fig3){ref-type="fig"} and [5C](#fig5){ref-type="fig"} require statistical analyses.

Thank you for pointing this out to us. The statistical analysis of the petal break-strength assays shown in [Figures 3A](#fig3){ref-type="fig"} and [5C](#fig5){ref-type="fig"} has been carried out by Prof. Ludwig A. Hothorn, Institute for Biostatistics, University of Hannover, Germany, whom we have added as an author on our manuscript:

Statistical analysis for [Figure 3A](#fig3){ref-type="fig"}: The statistical analysis is described in the figure legend of [Figure 3A](#fig3){ref-type="fig"}; statistical significant changes are indicated by a \* in the Figure itself. The revised figure legend reads: "Petal break-strength assays measure the force (expressed in gram equivalents) required to remove the petals from the flower of *serk* mutant plants compared to *haesa/hsl2* mutant and Col-0 wild-type flowers. \[...\] Petal break was found significantly increased in almost all positions (indicated with a \*) for *haesa/hsl2* and *serk1-1* mutant plants with respect to the Col-0 control. Calculations were performed in R (R Core Team 2014) (version 3.2.3)." The two new references have been added to the Reference section of the manuscript.

We have changed our Results section accordingly: "Our experiments suggest that among the SERK family members, SERK1 is a positive regulator offloral abscission. We found that the force required to remove the petals of *serk1-1* mutants is significantlyhigher than that needed for wild-type plants, as previously observed for *haesa/hsl2* mutants (Stenvik et al. 2008), and that floral abscission is delayed in *serk1-1* ([Figure 3A](#fig3){ref-type="fig"}). The *serk2-2, serk3-1, serk4-1 and serk5-1* mutant lines (Albrecht et al. 2008) showed a petal break-strength profile not significantly differentfrom wild-type plants."

Statistical analysis for [Figure 5C](#fig5){ref-type="fig"}: The statistical analysis is described in the figure legend of [Figure 5C](#fig5){ref-type="fig"}; statistical significant changes are indicated by \* and \# symbols in the Figure itself. The revised figure legend reads:"Quantitative petal break assay for Col-0 wild-type flowers and 35S::IDA wild-type and 35S::IDA K66A/R67A mutant flowers. \[...\] Up to inflorescence position 4, petal break in 35S::IDA K66A/R67A mutant plants was significantly increased compared to both Col-0 control plants (b) and 35S::IDA plants (c).**"**

We have changed our Results section accordingly: "We overexpressed full-length wild-type IDA or this Lys66^IDA^/Arg67^IDA^ → Ala double-mutant to similar levels in Col-0 Arabidopsis plants ([Figure 5D](#fig5){ref-type="fig"}). \[...\] Comparison of 35S::IDA wild-type and mutant plants further indicates that mutation of Lys66^IDA^/Arg67^IDA^→ Ala may cause a weak dominant negative effect ([Figure 5C-E](#fig5){ref-type="fig"})."

Following the suggestions from for example Nuzzo (Nature506:150-152, 2014) and Trafirmow and Marks (Basic and Applied Social Psychology37:1-2, 2015), we decided not to report p-values.

[^1]: Highest resolution shell is shown in parenthesis.

[^2]: *^\#^*As defined in XDS ([@bib25]).

[^3]: ^\$^As defined in Refmac5 ([@bib34]).

[^4]: Highest resolution shell is shown in parenthesis.

[^5]: *^\#^*As defined in XDS ([@bib25]).

[^6]: ^\$^As defined in Refmac5 ([@bib34]).
